Kanavos, Panos and Saka, Ömer R (2005) How should functionally equivalent drugs be reimbursed? A retrospective analysis of reimbursement for Epoetin-[alpha] and Darbepoetin-[alpha] in 2001-2003 and the cost implications for CMS. Disease management and health outcomes, 13 (6). pp. 359-370. ISSN 1173-8790
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Official URL: | http://diseasemanagement.adisonline.com/ |
| Additional Information: | © 2005 Adis International Ltd |
| Library of Congress subject classification: | R Medicine > RA Public aspects of medicine |
| Sets: | Departments > Social Policy Departments > European Institute Research centres and groups > LSE Health |
| Rights: | http://www.lse.ac.uk/library/rights/LSERO.htm |
| URL: | http://eprints.lse.ac.uk/15045/ |
Actions (login required)
![]() |
Record administration - authorised staff only |
